Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corey A Carter

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Current Opinion in Oncology|February 9, 2012
Treatment of nonsmall cell lung cancer: overcoming the resistance to epidermal growth factor receptor inhibitorsCorey A Carter, Giuseppe Giaccone
Expert Opinion on Pharmacotherapy|January 9, 2013
Dacomitinib, a new therapy for the treatment of non-small cell lung cancerChristina Brzezniak, Corey A Carter, Giuseppe Giaccone
Cases Journal|November 18, 2009
Plantar erythrodysesthesia with bullous otitis externa, toxicities from sorafenib: a case reportCorey A Carter, Arun Rajan, Giuseppe Giaccone
Expert Opinion on Investigational Drugs|November 27, 2009
Small-molecule inhibitors of the human epidermal receptor familyCorey A Carter, Ronan J Kelly, Giuseppe Giaccone
Postgraduate Medicine|November 12, 2014
Molecular targets in the treatment of non-small-cell lung cancer: is there hope on the horizon?Corey A Carter, Joel Anthony Nations, Angeline Lazarus
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2012
HER2 mutations in non-small-cell lung cancer can be continually targetedRonan J Kelly, Corey A Carter, Giuseppe Giaccone
Current Opinion in Investigational Drugs (London, England : 2000)|November 28, 2009
The role of KRAS mutations in resistance to EGFR inhibition in the treatment of cancerAriel Lopez-Chavez, Corey A Carter, Giuseppe Giaccone
JAAD Case Reports|April 7, 2016
Tracheal squamous cell carcinoma (SCC) metastatic to the skin in a patient on a checkpoint inhibitorNicole M Cassler, Jason D Marquart, Corey A Carter
Journal of Thoracic Disease|April 29, 2017
Recalcitrant small cell lung cancer: the argument for optimismKaren G Zeman, Christina E Brzezniak, Corey A Carter
Neoplasia (New York, N.Y.)|September 10, 2017
What's New in SCLC? A ReviewBryan Oronsky, Tony R Reid, Arnold Oronsky, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Current Opinion in Oncology|February 9, 2012
Treatment of nonsmall cell lung cancer: overcoming the resistance to epidermal growth factor receptor inhibitorsCorey A Carter, Giuseppe Giaccone
Expert Opinion on Pharmacotherapy|January 9, 2013
Dacomitinib, a new therapy for the treatment of non-small cell lung cancerChristina Brzezniak, Corey A Carter, Giuseppe Giaccone
Cases Journal|November 18, 2009
Plantar erythrodysesthesia with bullous otitis externa, toxicities from sorafenib: a case reportCorey A Carter, Arun Rajan, Giuseppe Giaccone
Expert Opinion on Investigational Drugs|November 27, 2009
Small-molecule inhibitors of the human epidermal receptor familyCorey A Carter, Ronan J Kelly, Giuseppe Giaccone
Postgraduate Medicine|November 12, 2014
Molecular targets in the treatment of non-small-cell lung cancer: is there hope on the horizon?Corey A Carter, Joel Anthony Nations, Angeline Lazarus
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2012
HER2 mutations in non-small-cell lung cancer can be continually targetedRonan J Kelly, Corey A Carter, Giuseppe Giaccone
Current Opinion in Investigational Drugs (London, England : 2000)|November 28, 2009
The role of KRAS mutations in resistance to EGFR inhibition in the treatment of cancerAriel Lopez-Chavez, Corey A Carter, Giuseppe Giaccone
JAAD Case Reports|April 7, 2016
Tracheal squamous cell carcinoma (SCC) metastatic to the skin in a patient on a checkpoint inhibitorNicole M Cassler, Jason D Marquart, Corey A Carter
Journal of Thoracic Disease|April 29, 2017
Recalcitrant small cell lung cancer: the argument for optimismKaren G Zeman, Christina E Brzezniak, Corey A Carter
Neoplasia (New York, N.Y.)|September 10, 2017
What's New in SCLC? A ReviewBryan Oronsky, Tony R Reid, Arnold Oronsky, et al.
Pageof 6